Suppr超能文献

硫胺素治疗对感染性休克患者乳酸清除率和死亡率的影响。

Effect of Thiamine Administration on Lactate Clearance and Mortality in Patients With Septic Shock.

机构信息

Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY.

University of Kentucky College of Public Health, Lexington, KY.

出版信息

Crit Care Med. 2018 Nov;46(11):1747-1752. doi: 10.1097/CCM.0000000000003311.

Abstract

OBJECTIVES

Mounting evidence has shown that critically ill patients are commonly thiamine deficient. We sought to test the hypothesis that critically ill patients with septic shock exposed to thiamine would demonstrate improved lactate clearance and more favorable clinical outcomes compared with those not receiving thiamine.

DESIGN

Retrospective, single-center, matched cohort study.

SETTING

Tertiary care academic medical center.

PATIENTS

Adult patients admitted with an International Classification of Diseases, 9th Edition, or International Classification of Diseases, 10th Edition, diagnosis code of septic shock to either the medicine or surgery ICU.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Patients who received IV thiamine supplementation within 24 hours of hospital admission were identified and compared with a matched cohort of patients not receiving thiamine. The primary objective was to determine if thiamine administration was associated with a reduced time to lactate clearance in septic shock. Secondary outcomes included 28-day mortality, acute kidney injury, and need for renal replacement therapy, and vasopressor and mechanical ventilation-free days. Two-thousand two-hundred seventy-two patients were screened, of whom 1,049 were eligible. The study consisted of 123 thiamine-treated patients matched with 246 patients who did not receive thiamine. Based on the Fine-Gray survival model, treatment with thiamine was associated with an improved likelihood of lactate clearance (subdistribution hazard ratio, 1.307; 95% CI, 1.002-1.704). Thiamine administration was also associated with a reduction in 28-day mortality (hazard ratio, 0.666; 95% CI, 0.490-0.905). There were no differences in any secondary outcomes.

CONCLUSIONS

Thiamine administration within 24 hours of admission in patients presenting with septic shock was associated with improved lactate clearance and a reduction in 28-day mortality compared with matched controls.

摘要

目的

越来越多的证据表明,危重症患者通常存在硫胺素缺乏。我们试图验证这样一个假设,即与未接受硫胺素治疗的患者相比,接受硫胺素治疗的伴有脓毒性休克的危重症患者的乳酸清除率会提高,临床结局会更有利。

设计

回顾性、单中心、匹配队列研究。

地点

三级保健学术医疗中心。

患者

收入院时的国际疾病分类第 9 版或第 10 版诊断代码为脓毒性休克的成年患者,收入内科或外科 ICU。

干预措施

无。

测量和主要结果

确定在入院后 24 小时内接受静脉硫胺素补充的患者,并与未接受硫胺素治疗的匹配队列患者进行比较。主要目的是确定硫胺素给药是否与脓毒性休克患者乳酸清除时间的缩短有关。次要结局包括 28 天死亡率、急性肾损伤和需要肾脏替代治疗、血管加压素和机械通气无天数。筛选了 2272 名患者,其中 1049 名符合条件。研究包括 123 名接受硫胺素治疗的患者和 246 名未接受硫胺素治疗的患者。基于 Fine-Gray 生存模型,硫胺素治疗与乳酸清除率提高的可能性相关(亚分布风险比,1.307;95%CI,1.002-1.704)。硫胺素给药也与 28 天死亡率降低相关(风险比,0.666;95%CI,0.490-0.905)。次要结局均无差异。

结论

与匹配对照组相比,在脓毒性休克患者入院后 24 小时内给予硫胺素治疗可改善乳酸清除率,降低 28 天死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验